Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)
BI 1015550 在进行性肺纤维化患者中的 III 期双盲、随机、安慰剂对照试验设计(FIBRONEER-ILD)
期刊:Bmj Open Respiratory Research
影响因子:3.4
doi:10.1136/bmjresp-2022-001580
Maher, Toby M; Assassi, Shervin; Azuma, Arata; Cottin, Vincent; Hoffmann-Vold, Anna-Maria; Kreuter, Michael; Oldham, Justin M; Richeldi, Luca; Valenzuela, Claudia; Wijsenbeek, Marlies S; Coeck, Carl; Schlecker, Christina; Voss, Florian; Wachtlin, Daniel; Martinez, Fernando J